Biopharma manufacturing ‘turbulence’ boosts inquiries for India-based providers, local CDMO execs say

India-based CDMOs have detected an uptick in biopharma client interest in their biologics and early-phase clinical offerings – and these manufacturers are accordingly adjusting their …

Source: https://endpoints.news